Chai Discovery Wins GSK Deal, Extending Pharma Run to Six Partnerships in Nine Months
AI drug-discovery startup Chai Discovery has secured a collaboration with GSK after what the companies described as successful wet-lab validation, marking the companyโs sixth pharmaceutical partnership in the past nine months. The deal underscores how quickly leading drugmakers are moving from evaluating generative AI models to signing commercial collaborations when early laboratory results appear credible.
